FdaApplication
NDA 022341
Identifiers
- fda_app_no: NDA022341
Properties
| Property | Value |
|---|---|
| applicant_name | NOVO NORDISK INC |
| application_type | NDA |
| approval_date | 2010-01-25 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VICTOZA | LIRAGLUTIDE | 18MG/3ML (6MG/ML) | SOLUTION;SUBCUTANEOUS |
1 product